A detailed history of Russell Investments Group, Ltd. transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 301,225 shares of HBIO stock, worth $629,560. This represents 0.0% of its overall portfolio holdings.

Number of Shares
301,225
Previous 423,021 28.79%
Holding current value
$629,560
Previous $1.21 Million 32.78%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$2.64 - $3.54 $321,541 - $431,157
-121,796 Reduced 28.79%
301,225 $810,000
Q2 2024

Aug 08, 2024

BUY
$2.77 - $4.63 $1.17 Million - $1.96 Million
422,967 Added 783272.25%
423,021 $1.21 Million
Q4 2023

Feb 05, 2024

SELL
$4.0 - $5.49 $356 - $488
-89 Reduced 62.24%
54 $0
Q3 2023

Nov 13, 2023

BUY
$4.0 - $5.82 $572 - $832
143 New
143 $0
Q2 2021

Aug 04, 2021

SELL
$5.44 - $8.4 $51,130 - $78,951
-9,399 Closed
0 $0
Q1 2021

May 10, 2021

SELL
$3.91 - $6.99 $45,707 - $81,713
-11,690 Reduced 55.43%
9,399 $51,000
Q4 2020

Feb 08, 2021

SELL
$3.0 - $4.5 $3 - $4
-1 Reduced -0.0%
21,089 $90,000
Q3 2020

Nov 09, 2020

SELL
$2.75 - $4.2 $4,581 - $6,997
-1,666 Reduced 7.32%
21,090 $63,000
Q2 2020

Aug 05, 2020

BUY
$2.12 - $3.14 $19,925 - $29,512
9,399 Added 70.37%
22,756 $70,000
Q3 2019

Nov 01, 2019

SELL
$1.59 - $3.47 $570,032 - $1.24 Million
-358,511 Reduced 96.41%
13,357 $40,000
Q2 2019

Aug 09, 2019

BUY
$1.93 - $4.59 $24,167 - $57,475
12,522 Added 3.48%
371,868 $745,000
Q1 2019

May 13, 2019

BUY
$2.77 - $4.38 $933,791 - $1.48 Million
337,109 Added 1515.98%
359,346 $1.55 Million
Q4 2018

Feb 11, 2019

SELL
$3.03 - $5.0 $11,880 - $19,605
-3,921 Reduced 14.99%
22,237 $68,000
Q2 2018

Aug 08, 2018

SELL
$4.2 - $5.95 $45,780 - $64,855
-10,900 Reduced 29.41%
26,158 $137,000
Q1 2018

May 11, 2018

BUY
$3.3 - $5.15 $35,970 - $56,135
10,900 Added 41.67%
37,058 $186,000
Q3 2017

Nov 07, 2017

BUY
$2.7 - $3.75 $70,626 - $98,092
26,158
26,158 $98,000

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $87M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.